Compare · AXNX vs BDX

AXNX vs BDX

Side-by-side comparison of Axonex AI Group Limited (AXNX) and Becton Dickinson and Company (BDX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • AXNX operates in Consumer Discretionary, while BDX operates in Health Care - the two are in different parts of the market.
  • BDX is the larger of the two at $58.96B, about 9369.0x AXNX ($6.3M).
  • BDX has hit the wire 11 times in the past 4 weeks while AXNX has been quiet.
  • BDX has more recent analyst coverage (25 ratings vs 21 for AXNX).
MetricAXNXBDX
Company
Axonex AI Group Limited
Becton Dickinson and Company
Price
-
-
Market cap
$6.3M
$58.96B
1M return
-
+12.87%
1Y return
-
+44.14%
Industry
Business Services
Medical/Dental Instruments
Exchange
NASDAQ
NYSE
IPO
2018
News (4w)
0
11
Recent ratings
21
25
AXNX

Axonex AI Group Limited

Axonex AI Group Limited (formerly Mint Incorporation Limited) (NASDAQ: AXNX) is a Hong Kong-based company strategically focused on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider. Through its subsidiary, Axonex AI Limited, and its majority owned subsidiary, Rice Robotics AGI Holding Limited, the Group delivers robot models and robotics solutions, including the FLOKI Minibot M1 and micro-insurance solutions purpose-built for commercial robots. The Group also maintains its established interior design and fit-out works business. Anchored by its ongoing transformation, Axonex AI is focused on AI and robotics as its main growth driving engine.

BDX

Becton Dickinson and Company

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.

Latest AXNX

Latest BDX